As we demonstrated that the intrinsic activation of SHH signaling was mainly due to Gli1 overexpression in response to EWS-FLI1, we then assessed the effects of the specific Gli inhibitor GANT61 on primary ES tumor growth. Here, FLI1 is linked to neoplasm.